Key facts
- On Target Laboratories’s last known valuation is $65.6M (Jan 2025).
- It has raised $134.4M; the latest was Later Stage VC ($19.6M) in Jan 2025.
- Notable investors include Elevate Ventures, Johnson & Johnson Innovation - JLABS, Johnson & Johnson JJDC, H.I.G. Capital, Helsinn Healthcare — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for On Target Laboratories
- ·The full record, as it builds
Funding rounds
No funding rounds for On Target Laboratories are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About On Target Laboratories
Developer of a fluorescent imaging technology designed to target and illuminate cancer during surgery. The company's technology reduces the uncertainty associated with finding and removing diseased tissue during medical procedures, enabling surgeons to have the benefit of intraoperative sight.
- Sector
- Healthcare
- HQ
- West Lafayette, IN, United States
- Founded
- 2010
- Employees
- 45
- Website
- ontargetlabs.com/
- Ownership
- Privately Held (backing)
On Target Laboratories doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in On Target Laboratories shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on On Target Laboratories in its N-PORT filings yet. We sweep new filings monthly.